PhRMA
AUGUST 12, 2022
With a final vote in Congress expected on a reconciliation spending bill, a new Morning Consult survey explores what this legislation actually does – and does not do – and finds that voters are skeptical of its impact on inflation, worried about the consequences of Medicare “negotiation” and concerned the bill doesn’t do enough to help make medicines affordable for patients.
Pharmaceutical Technology
AUGUST 12, 2022
In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. The FDA’s breakthrough device programme is for medical devices or device-led combination products that provide more effective treatment or diagnosis of diseases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Thyroid Pharmacist
AUGUST 12, 2022
Did you know that most cases of thyroid disease are autoimmune in nature? (1). Hashimoto’s thyroiditis is an autoimmune condition that happens to affect the thyroid gland. This means that our immune system recognizes the thyroid gland as a foreign invader and begins to attack it, eventually leading to the destruction of our thyroid tissue. When this destruction goes on long enough, the person will lose their ability to produce thyroid hormone.
Pharmacy Times
AUGUST 12, 2022
The Prescription Information Modernization Act seeks to modernize health care with up-to-date digital prescribing information to pharmacists.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
AUGUST 12, 2022
The US Food and Drug Administration (FDA) has granted approval for Daiichi Sankyo and AstraZeneca ’s Enhertu (fam-trastuzumab deruxtecan-nxki) to treat unresectable or metastatic non-small cell lung cancer (NSCLC) in adults. The treatment is indicated for such patients whose tumours have activating HER2 (ERBB2) mutations and previously received systemic therapy. .
Pharmacy Times
AUGUST 12, 2022
A daily serving of meat can increase the risk of cardiovascular disease by 22% and our own gut microbes may contribute to this risk.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 12, 2022
Lyme disease has reportedly spread geographically and increased in rural and urban populations during the past 15 years.
Pharmaceutical Technology
AUGUST 12, 2022
In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The plan, which was released in late June, outlines a science strategy to improve research efforts for ALS. Its content is pertinent given the upcoming FDA Advisory Committee (AdCom) for Amylyx Pharmaceuticals’ ALS drug AMX0035 on 7 September.
Pharmacy Times
AUGUST 12, 2022
New study shows that race does not influence outcomes from immunotherapy for aggressive triple-negative breast cancer.
The Guardian - Pharmaceutical Industry
AUGUST 12, 2022
Drug can help prevent infection in people who are immunocompromised but government says data is lacking The UK will not buy the drug Evusheld, which can help prevent Covid infections in people with weakened immune systems, the government has said. The decision, revealed on Friday in an official statement to BBC Radio 4’s Today programme, has been met with criticism from a host of charities who say it means many people who are immunocompromised will be left with no option but to avoid contact wit
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 12, 2022
Researchers studying the gut microbiome found that fiber supplements of any kind could improve gut health.
European Pharmaceutical Review
AUGUST 12, 2022
According to researchers, binding nasal vaccine antigens to albumin enables them to bypass mucosal barriers, and could lead to better protection against pathogens like HIV and Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2; the virus that causes COVID-19). The University of Minnesota researchers tested the technology on mice and non-human primates and found that the vaccine generated strong immune responses, paving the way for further study and development of nasal vaccines.
Pharmacy Times
AUGUST 12, 2022
Organizational determinants can play an important role in whether or not MTM programs are successful.
Digital Pharmacist
AUGUST 12, 2022
Back to school can be a crazy time. With shopping for supplies, possibly moving a college-aged student, and trying to soak in the last few days of summer – it can be a lot on families. So, what can we do at the pharmacy to help ease this burden? How can we help our communities have a smooth back to school transition? In today’s blog, we’re going to provide you with a few tips. .
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
AUGUST 12, 2022
The FDA approval of fam-trastuzumab deruxtecan-nxki (Enhertu) to treat HER2 mutant non-small cell lung cancer was based on results from the DESTINY-Lung02 phase 2 trial.
European Pharmaceutical Review
AUGUST 12, 2022
Since ophthalmic preparations are typically manufactured aseptically, with sterility ensured by sterile filtration rather than terminal sterilisation, literature about the effects of terminal sterilisation on these products is limited. Thus, researchers set out to establish whether the quality of common ophthalmic active pharmaceutical ingredients (APIs) still complies with the specifications of the European Pharmacopoeia (Ph.
Pharmacy Times
AUGUST 12, 2022
Hearing and vision may not be considered hierarchically superior senses anymore, as a new study sheds light on the importance of taste and smell for quality of life.
The Guardian - Pharmaceutical Industry
AUGUST 12, 2022
Company has faced lawsuits about its talc products but insists they are safe Johnson & Johnson is to stop selling and making talc-based baby powder globally, two years after it ended sales in the US and Canada. The healthcare firm has faced tens of thousands of lawsuits from consumers who allege its talc products, including the instantly recognisable brand of Johnson’s baby powder, caused them to develop cancer.
Pharmacy Times
AUGUST 12, 2022
ZuPOO is indicated for gut support, and specifically for colon and gut cleansing.
pharmaphorum
AUGUST 12, 2022
Recent history should have the pharmaceutical industry questioning some of its fundamental assumptions. The COVID-19 pandemic led to skyrocketing demand for some products while simultaneously constraining supplies due to logistical breakdowns and protectionist practices. The logic of outsourcing production to other countries, primarily China, suddenly looked dubious as Western countries struggled to import the drugs they needed.
Pharmacy Times
AUGUST 12, 2022
Pharmacists discuss barriers contributing to vaccine reluctance among young adults, including varying degrees of education, accessibility, and convenience.
Compounding Pharmacy of America
AUGUST 12, 2022
Having a strong immune system that’s ready to battle the different colds and viruses that come your way is essential, especially when you’re a child in school. Kids face a multitude of different germs, bacteria, and viruses every day between the different surfaces they touch and the objects they share at school. Because of everything […]. The post How to Strengthen Your Child’s Immune System Before School Starts appeared first on The Compounding Pharmacy of America.
Pharmacy Times
AUGUST 12, 2022
The expert panel illustrate the changing roles of pharmacists and technicians as healthcare expands and evolves from the impact of the COVID-19 pandemic.
Aureus Medical Group
AUGUST 12, 2022
By Sarah Wengert. Many different titles and credentials exist in the healthcare field, and each comes with its own requirements for education, testing, and on-the-job experience. In nursing, the most common titles are certified nursing assistant (CNA), licensed practical nurse (LPN)/licensed vocational nurse (LVN), and registered nurse (RN). As a travel nursing and allied health agency , we often get questions about how working nurses can best transition from one title to another.
Pharmacy Times
AUGUST 12, 2022
Xenia Tigno, PhD, and Reshma Jagsi, MD, DPhil, discuss how professional and societal pressures around the legitimacy of maternal leave versus paternal leave can impact the trajectory of women’s careers in medical research.
The Honest Apothecary
AUGUST 12, 2022
I don’t always do it perfectly, or even very well. Every day I want to get better. But I am 100% convinced that being a successful manager, director, VP, or C-suite executive means putting people first. It means my direct reports are more important than my email. It means my team is more important than some project. It means helping another person in my organization be more successful in their career takes priority over another Zoom meeting with an eager salesperson. lt means that acknowle
Pharmacy Times
AUGUST 12, 2022
Health care providers’ recommendations will make a difference, results of a new poll from the University of Michigan show.
pharmaphorum
AUGUST 12, 2022
Johnson & Johnson has said it will stop selling talc-based baby powder products globally next year, two years after halting sales in the US and Canada. The company said the decision to replace its talc Baby Powder with a cornstarch-based version has been taken as “part of a worldwide portfolio assessment,” and reiterated that its position on the safety of talc – the subject of ongoing and expensive litigation – remains unchanged. “We stand firmly behind the decades of indep
Pharmacy Times
AUGUST 12, 2022
Topline results from the KarMMa-3 trial show that idecabtagene vicleucel significantly improves progression-free survival vs standard regimens.
pharmaphorum
AUGUST 12, 2022
Patient recruitment specialist Clariness will deploy an app aimed at helping asthma patients monitor environment triggers and report symptoms in the clinical trials its support, thanks to a partnership with digital health firm DailyBreath. The app – also called DailyBreath and available via Google Play or the App Store – gives people with asthma data on environmental conditions that can affect their illness, like pollution, weather conditions and allergens such as pollen.
Pharmacy Times
AUGUST 12, 2022
Meropenem and vaborbactam is indicated for the treatment of complicated urinary tract infections for patients aged 18 years and older.
Pharmaceutical Technology
AUGUST 12, 2022
Ceapro has extended a partnership underway to carry out a further research project with McMaster University for developing an inhalable immuno-therapeutic/-prophylactic for Covid-19-induced lung fibrosis. This project is intended to develop therapies for people suffering from Covid-19’s long-term effects. In August 2019, the parties entered a partnership for new drug delivery system development leveraging the disruptive Pressurized Gas eXpanded Liquid technology (PGX) to streamline drug formulat
PQA
AUGUST 12, 2022
We are excited to announce that we will be open registration for the 2022 PQA Leadership Summit later this month. This year's summit will take place November 10-11 in Arlington, Va., and explore quality and value in medication use from patient, provider, purchaser, payer and industry perspectives. One individual from each PQA member organization is invited to attend the Leadership Summit.
Therapeutics Education Collaboration
AUGUST 12, 2022
Episode 517: PREMIUM – A podcast that hopefully won’t leave you breathless. In episode 517, Mike and James talk PREMIUMLY (not a word but it should be) about two new trials that looked at using fixed dose combinations of salbutamol/albuterol and a steroid on a PRN basis in patients with moderate to severe asthma. It seems to have an effect and it may make asthma treatment simpler, but it may also increase the costs when it comes to inhalers.
Expert insights. Personalized for you.
161 
Let's personalize your content